DOSAGE REGIMEN OF AN S1P RECEPTOR MODULATOR

S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.

Saved in:
Bibliographic Details
Main Authors David, Olivier, de Vera, Ana, Dumortier, Thomas, Burtin, Pascale, Hunt, Irene, Schmouder, Robert, Boulton, Craig
Format Patent
LanguageEnglish
Published 23.03.2023
Subjects
DIAGNOSIS
HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
HUMAN NECESSITIES
HYGIENE
IDENTIFICATION
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SURGERY
TESTING
Online AccessGet full text

Cover

More Information
Summary:S1P receptor modulators are administered following a dosage regimen providing a positive benefit-risk profile.
Bibliography:Application Number: US202217731920